Pregnancy and pulmonary arterial hypertension
Copyright © 2019 Elsevier Masson SAS. All rights reserved..
Pulmonary hypertension in pregnant women is associated with high mortality and morbidity despite significant improvement in prognosis. Women with pulmonary arterial hypertension (PAH) should be still advised against pregnancy and advised on effective contraceptive methods. Pregnancy may be manageable in women with well controlled PAH or mild pulmonary hypertension (sPAP<50mmHg). When women with PAH choose to continue their pregnancy, they need: management by a multidisciplinary team in an expert centre; continuation or early introduction of targeted PAH therapy; early planned delivery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
---|---|
Enthalten in: |
Presse medicale (Paris, France : 1983) - 48(2019), 12 vom: 15. Dez., Seite 1422-1430 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Grossesse et hypertension artérielle pulmonaire |
---|
Beteiligte Personen: |
Ladouceur, Magalie [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 25.12.2019 Date Revised 25.12.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.lpm.2019.08.007 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM302842586 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM302842586 | ||
003 | DE-627 | ||
005 | 20231225111558.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1016/j.lpm.2019.08.007 |2 doi | |
028 | 5 | 2 | |a pubmed24n1009.xml |
035 | |a (DE-627)NLM302842586 | ||
035 | |a (NLM)31679895 | ||
035 | |a (PII)S0755-4982(19)30357-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Ladouceur, Magalie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pregnancy and pulmonary arterial hypertension |
246 | 3 | 3 | |a Grossesse et hypertension artérielle pulmonaire |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.12.2019 | ||
500 | |a Date Revised 25.12.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 Elsevier Masson SAS. All rights reserved. | ||
520 | |a Pulmonary hypertension in pregnant women is associated with high mortality and morbidity despite significant improvement in prognosis. Women with pulmonary arterial hypertension (PAH) should be still advised against pregnancy and advised on effective contraceptive methods. Pregnancy may be manageable in women with well controlled PAH or mild pulmonary hypertension (sPAP<50mmHg). When women with PAH choose to continue their pregnancy, they need: management by a multidisciplinary team in an expert centre; continuation or early introduction of targeted PAH therapy; early planned delivery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Vasodilator Agents |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Presse medicale (Paris, France : 1983) |d 1986 |g 48(2019), 12 vom: 15. Dez., Seite 1422-1430 |w (DE-627)NLM012618160 |x 2213-0276 |7 nnns |
773 | 1 | 8 | |g volume:48 |g year:2019 |g number:12 |g day:15 |g month:12 |g pages:1422-1430 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lpm.2019.08.007 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 48 |j 2019 |e 12 |b 15 |c 12 |h 1422-1430 |